Although the sporadic and genetic form of AD share similar pathomechanisms, sporadic AD patients are on average 20–30 years older at symptom onset and other age-related comorbidities may impact NfL levels and dynamics31. This evidence concerns the gene NEFL and Alzheimer disease.